摘要
The authors regret <the error in affiliated institute. Now the error is corrected as below.>. The authors would like to apologise for any inconvenience caused. Liqiang Sua,1, Jiahui Lib,c,1, Zhen Zhoua, Dongxia Huanga, Yuanjin Zhanga, Haixiang Peia, Weikai Guoa, Haigang Wua, Xin Wanga, Mingyao Liua, Cai-Guang Yangb,c,∗∗, Yihua Chena,∗a Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China. b State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. c University of the Chinese Academy of Sciences, Beijing 100049, China.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 385 |
| 页数 | 1 |
| 期刊 | European Journal of Medicinal Chemistry |
| 卷 | 168 |
| DOI |
|
| 出版状态 | 已出版 - 15 4月 2019 |
指纹
探究 'Corrigendum to “Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents” [Eur. J. Med. Chem. 162 (162) (2019) 203–211](S022352341830970X)(10.1016/j.ejmech.2018.11.016)' 的科研主题。它们共同构成独一无二的指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver